Livestock Vaccines: Market Size & Forecast 2026

The global livestock vaccines market encompasses a broad range of immunoprophylactic products designed to prevent infectious diseases in economically important animal species including cattle, swine, poultry, and aquaculture. The market's valuation of $18.99 billion in 2025 reflects sustained investment in veterinary biologics and expanding animal healthcare budgets worldwide. Growth at 10.0% annually is supported by both companion animal and production animal segments, with production animals representing the larger share due to their critical role in food security.

• •Market valued at approximately $18.99 billion in 2025
• •Projected compound annual growth rate of 10.0%
• •Serves cattle, swine, poultry, and other livestock species

Rising global demand for meat, dairy, and eggs is a primary catalyst, as livestock producers seek to minimize disease-related losses in increasingly intensive farming systems. Heightened awareness of zoonotic diseases such as avian influenza and foot-and-mouth disease has prompted stricter biosecurity regulations and mandatory vaccination programs in many countries. Additionally, technological advancements in vaccine development, including recombinant and marker vaccines, are expanding the addressable market by offering safer and more effective disease prevention options.

• •Increasing global demand for animal protein driving vaccination adoption
• •Zoonotic disease concerns prompting stricter biosecurity and vaccination mandates
• •Advancements in recombinant and marker vaccine technology expanding market potential

The market is segmented by animal type into cattle, swine, poultry, and other species, with poultry vaccines representing a substantial share due to the high density and commercial scale of poultry farming globally. Geographically, North America holds the largest market share supported by advanced veterinary infrastructure and high livestock production standards. Europe follows closely, while the Asia-Pacific region is anticipated to grow at the fastest pace, fueled by expanding livestock populations, rising protein consumption, and improving veterinary services access in emerging economies.

• •Poultry segment holds significant share due to high-density commercial farming
• •North America leads with advanced veterinary infrastructure and regulatory support
• •Asia-Pacific projected for fastest growth driven by expanding livestock populations

What are the recent trends and outlook?

The market is increasingly shifting toward next-generation vaccine platforms including mRNA-based and vectored vaccines, which promise enhanced efficacy and faster development timelines for emerging disease threats. Digitalization and precision livestock farming technologies are also influencing vaccine delivery and disease management strategies, enabling targeted vaccination protocols. With continued global population growth and rising protein demand, the livestock vaccines market is well-positioned for sustained expansion, though factors such as vaccine hesitancy among some producers, cold chain logistics challenges, and evolving regulatory landscapes present ongoing considerations for stakeholders.

• •Emerging mRNA and vectored vaccine technologies gaining research and commercial attention
• •Digital and precision livestock farming tools enabling targeted vaccination strategies
• •Market growth expected to remain robust amid rising global protein demand